|
2024
|
Invention
|
Therapeutic uses and methods.
The specification discloses a method of treating muscular disorder... |
|
|
Invention
|
Combination compositions and methods for treatment of muscular dystrophy. Disclosed herein are co... |
|
2023
|
Invention
|
Biomarkers and uses thereof in diagnosis and treatment of neurological post acute sequelae of cov... |
|
2022
|
Invention
|
Methods and kits therefor. Disclosed herein are methods and related composition for administratio... |
|
2021
|
Invention
|
Combination therapy.
The present disclosure relates to a method for treatment or prevention of d... |
|
2020
|
Invention
|
Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49d.
A method of ... |
|
|
Invention
|
Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49d. A method of m... |
|
2019
|
Invention
|
Therapeutic uses and methods. The specification discloses a method of treating muscular disorders... |
|
2018
|
Invention
|
Therapeutic uses and methods. A method of treating muscular dystrophy in a subject or for improvi... |
|
|
Invention
|
Methods for treating multiple sclerosis using antisense oligonucleotides. A method for treating a... |
|
|
Invention
|
Mobilizing leukemia cells. MeC), or a pharmaceutically acceptable salt thereof. |
|
2016
|
Invention
|
"mobilizing leukemia cells". A method for mobilizing leukemia cells which are α4 integrin positiv... |
|
|
Invention
|
Modulation of growth hormone receptor expression and insulin-like growth factor expression. Compo... |
|
|
Invention
|
Method for reducing circulating leukocytes in a human subject. The present disclosure relates to ... |
|
|
Invention
|
Combination therapy. The present disclosure relates to a method for treatment or prevention of di... |
|
2015
|
Invention
|
Modulation of insulin like growth factor i receptor expression in cancer.
Provided herein are me... |
|
2013
|
Invention
|
Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the gr... |
|
2012
|
Invention
|
Modulation of insulin like growth factor i receptor expression.
The present invention provides c... |
|
2011
|
Invention
|
Method for mobilizing stem and/or progenitor cells.
The present disclosure relates to methods fo... |
|
|
Invention
|
Method for mobilizing stem and/or progenitor cells. The present disclosure relates to methods for... |
|
2009
|
Invention
|
Modulation of insulin like growth factor i receptor expression in cancer. Provided herein are met... |
|
2008
|
Invention
|
Modulation of insulin like growth factor i receptor expression. The present invention provides co... |
|
2005
|
Invention
|
Topical administrations of antisense compounds to vla-4 for the treatment of respiratory conditio... |
|
|
Invention
|
Antisens modulation of integrin &agr;4 expression. A method for the treatment and/or prophylaxis ... |
|
1999
|
Invention
|
Antisense modulation of integrin .alpha.4 expression. Compositions and methods are provided for m... |
|
1998
|
Invention
|
Antisense inhibition of integrin .alpha.4 expression. Compositions and methods are provided for m... |
